French venture capital firm Seventure Partners is seeking to secure about 200 million euros ($225.9 million) for its second dedicated fund, Health for Life Capital II (HFL II).
The new fund intends to focus on opportunistic investments in digital therapeutics, connected health, digital nutritional advice, personalised nutrition, precision medicine and food technologies as well as the microbiome.
The new fund has already committed to its first two investments, that is, U.S. Axial Biotherapeutics and Galecto Biotech.
Moreso, HFL II aims to inject in a similar number of companies, with a global focus, spanning Europe, North America, Israel, and opportunistically Asia.